$117.22
가까이에: Nov 10 EDT
$117.44
0.220.19%
프리마켓: 7:29 AM EDT
Comments
Loading...
분석가 평가, 목표 가격, 예측
Exxon Mobil Corp의 컨센서스 목표 주가는 $128.64이며, 24명의 애널리스트 평가를 기반으로 합니다. 최고 목표가는 10월 17, 2025에 Wells Fargo가 발표한 $156이고, 최저 목표가는 5월 5, 2025에 RBC Capital가 발표한 $105입니다. 가장 최근의 애널리스트 평가 3건은 Scotiabank, Wells Fargo 및 UBS가 11월 3, 2025, 10월 17, 2025 및 10월 13, 2025에 발표했습니다. Scotiabank, Wells Fargo 및 UBS 사이의 평균 목표 주가는 $152이며, 이 최신 평가들로부터 Exxon Mobil Corp에 대한 29.43% upside가 시사됩니다.
추천을 하는 애널리스트 회사들1
Scotiabank
Wells Fargo
UBS
Barclays
Mizuho
1애널리스트 평가로부터 계산됨
Exxon Mobil에 대한 애널리스트 평점
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 31.98% | Scotiabank | $128 → $155 | Maintains | Sector Outperform | |||
10/17/2025 | 32.83% | Wells Fargo | → $156 | Initiates | → Overweight | |||
10/13/2025 | 23.47% | UBS | $143 → $145 | Maintains | Buy | |||
10/09/2025 | 8.99% | Scotiabank | $125 → $128 | Maintains | Sector Outperform | |||
10/07/2025 | 7.29% | Barclays | $127 → $126 | Maintains | Overweight | |||
09/15/2025 | 4.73% | Mizuho | $124 → $123 | Maintains | Neutral | |||
09/10/2025 | 2.18% | B of A Securities | $113 → $120 | Maintains | Neutral | |||
08/20/2025 | 21.76% | UBS | $130 → $143 | Maintains | Buy | |||
08/20/2025 | -5.48% | Melius Research | → $111 | Initiates | → Hold | |||
08/18/2025 | 23.47% | Piper Sandler | $134 → $145 | Maintains | Overweight | |||
08/08/2025 | -0.37% | Goldman Sachs | $117 → $117 | Reiterates | Neutral → Neutral | |||
08/05/2025 | 2.18% | HSBC | $119 → $120 | Maintains | Hold | |||
08/04/2025 | 14.95% | Morgan Stanley | $134 → $135 | Maintains | Overweight | |||
08/01/2025 | 5.59% | JP Morgan | $125 → $124 | Maintains | Overweight | |||
07/11/2025 | 6.44% | Scotiabank | $115 → $125 | Maintains | Sector Outperform | |||
07/08/2025 | 14.1% | Piper Sandler | $131 → $134 | Maintains | Overweight | |||
07/02/2025 | 11.55% | Piper Sandler | $125 → $131 | Maintains | Overweight | |||
06/26/2025 | 8.14% | Wells Fargo | $126 → $127 | Maintains | Overweight | |||
05/13/2025 | 6.44% | Piper Sandler | $127 → $125 | Maintains | Overweight | |||
05/13/2025 | 5.59% | Mizuho | $129 → $124 | Maintains | Neutral | |||
05/05/2025 | -10.59% | RBC Capital | $115 → $105 | Maintains | Sector Perform | |||
05/05/2025 | 8.14% | Barclays | $130 → $127 | Maintains | Overweight | |||
04/23/2025 | 10.69% | Barclays | $135 → $130 | Maintains | Overweight | |||
04/14/2025 | 11.55% | UBS | $135 → $131 | Maintains | Buy | |||
04/11/2025 | -2.08% | Scotiabank | $140 → $115 | Maintains | Sector Outperform | |||
04/07/2025 | 14.95% | UBS | $146 → $135 | Maintains | Buy | |||
04/03/2025 | 9.84% | Mizuho | $131 → $129 | Maintains | Neutral | |||
03/27/2025 | 17.51% | Morgan Stanley | $141 → $138 | Maintains | Overweight | |||
03/18/2025 | 14.95% | Barclays | $137 → $135 | Maintains | Overweight | |||
02/03/2025 | -2.08% | RBC Capital | $115 → $115 | Reiterates | Sector Perform → Sector Perform | |||
02/03/2025 | 14.95% | Wells Fargo | $136 → $135 | Maintains | Overweight | |||
01/13/2025 | 1.33% | Truist Securities | $117 → $119 | Maintains | Hold | |||
12/19/2024 | 8.14% | Piper Sandler | $138 → $127 | Maintains | Overweight | |||
12/16/2024 | 6.44% | JP Morgan | $130 → $125 | Maintains | Overweight | |||
12/16/2024 | 14.1% | Mizuho | $137 → $134 | Maintains | Neutral | |||
12/12/2024 | 25.17% | UBS | $149 → $147 | Maintains | Buy | |||
12/12/2024 | -2.08% | RBC Capital | $115 → $115 | Reiterates | Sector Perform → Sector Perform | |||
11/26/2024 | -2.08% | RBC Capital | $120 → $115 | Maintains | Sector Perform | |||
11/19/2024 | 12.4% | TD Cowen | $127 → $132 | Maintains | Buy | |||
11/04/2024 | 8.14% | TD Cowen | $130 → $127 | Maintains | Buy | |||
11/04/2024 | 2.18% | RBC Capital | $120 → $120 | Reiterates | Sector Perform → Sector Perform | |||
10/17/2024 | 5.59% | B of A Securities | → $124 | Reinstates | → Neutral | |||
10/10/2024 | 23.47% | Scotiabank | $129 → $145 | Upgrade | Sector Perform → Sector Outperform | |||
10/09/2024 | -10.59% | Exane BNP Paribas | → $105 | Downgrade | Neutral → Underperform | |||
10/08/2024 | 2.18% | RBC Capital | $120 → $120 | Reiterates | Sector Perform → Sector Perform | |||
10/04/2024 | 10.69% | BMO Capital | $127 → $130 | Maintains | Market Perform | |||
10/03/2024 | 16.66% | Barclays | $142 → $137 | Maintains | Overweight | |||
09/30/2024 | -0.37% | Truist Securities | $121 → $117 | Maintains | Hold | |||
09/27/2024 | 15.8% | Wells Fargo | $135 → $136 | Maintains | Overweight | |||
09/24/2024 | 2.18% | Redburn Atlantic | $119 → $120 | Downgrade | Buy → Neutral | |||
09/18/2024 | 26.87% | UBS | $157 → $149 | Maintains | Buy | |||
09/16/2024 | 20.91% | Morgan Stanley | $145 → $142 | Maintains | Overweight | |||
09/16/2024 | 10.69% | Mizuho | $128 → $130 | Maintains | Neutral | |||
08/20/2024 | 33.69% | UBS | $156 → $157 | Maintains | Buy | |||
08/05/2024 | 14.95% | Wells Fargo | $139 → $135 | Maintains | Overweight | |||
07/22/2024 | 3.03% | Truist Securities | $124 → $121 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Outperform | |||
07/17/2024 | 17.51% | Bernstein | $139 → $138 | Maintains | Outperform | |||
07/09/2024 | 20.91% | Barclays | $147 → $142 | Maintains | Overweight | |||
07/09/2024 | 14.95% | RBC Capital | $135 → $135 | Reiterates | Sector Perform → Sector Perform | |||
06/25/2024 | 31.13% | UBS | $152 → $154 | Maintains | Buy | |||
06/07/2024 | 5.59% | Truist Securities | $146 → $124 | Downgrade | Buy → Hold | |||
05/15/2024 | 23.47% | Morgan Stanley | → $145 | Reinstates | → Overweight | |||
05/13/2024 | 8.99% | Mizuho | $125 → $128 | Maintains | Neutral | |||
05/07/2024 | 29.43% | UBS | $150 → $152 | Maintains | Buy | |||
04/30/2024 | 2.18% | HSBC | $111 → $120 | Maintains | Hold | |||
04/30/2024 | 14.95% | TD Cowen | $128 → $135 | Maintains | Buy | |||
04/30/2024 | 20.91% | Wells Fargo | $138 → $142 | Maintains | Overweight | |||
04/18/2024 | 23.47% | Piper Sandler | $130 → $145 | Maintains | Overweight | |||
04/11/2024 | 27.72% | UBS | $133 → $150 | Maintains | Buy | |||
04/11/2024 | 9.84% | Scotiabank | $114 → $129 | Maintains | Sector Perform | |||
04/10/2024 | 25.17% | Barclays | → $147 | Initiates | → Overweight | |||
04/05/2024 | 24.32% | Truist Securities | $140 → $146 | Maintains | Buy | |||
04/04/2024 | 17.51% | Wells Fargo | $126 → $138 | Maintains | Overweight | |||
04/04/2024 | 6.44% | Mizuho | $125 → $125 | Reiterates | Neutral → Neutral | |||
04/01/2024 | 2.18% | TD Cowen | $115 → $120 | Maintains | Buy | |||
03/19/2024 | 6.44% | Mizuho | $119 → $125 | Maintains | Neutral | |||
03/14/2024 | 10.69% | Piper Sandler | $142 → $130 | Maintains | Overweight | |||
02/05/2024 | 2.18% | RBC Capital | $120 → $120 | Reiterates | Sector Perform → Sector Perform | |||
01/23/2024 | 12.4% | UBS | $133 → $132 | Maintains | Buy | |||
01/23/2024 | -2.08% | TD Cowen | → $115 | Upgrade | Market Perform → Outperform | |||
01/09/2024 | 1.33% | Redburn Atlantic | $116 → $119 | Upgrade | Neutral → Buy | |||
01/03/2024 | -0.37% | Mizuho | → $117 | Downgrade | Buy → Neutral | |||
12/22/2023 | — | Erste Group | — | Downgrade | Buy → Hold | |||
12/14/2023 | 13.25% | UBS | $138 → $133 | Maintains | Buy | |||
12/08/2023 | 8.14% | JP Morgan | $134 → $127 | Maintains | Overweight | |||
12/07/2023 | 2.18% | RBC Capital | $120 → $120 | Reiterates | Sector Perform → Sector Perform | |||
11/14/2023 | 13.25% | Mizuho | $139 → $133 | Maintains | Buy | |||
11/02/2023 | 20.91% | UBS | $143 → $142 | Maintains | Buy | |||
10/25/2023 | 14.1% | JP Morgan | $137 → $134 | Maintains | Overweight | |||
10/17/2023 | 19.21% | Bernstein | → $140 | Initiates | → Outperform | |||
10/12/2023 | 23.47% | Jefferies | $140 → $145 | Maintains | Buy | |||
10/12/2023 | 2.18% | RBC Capital | → $120 | Reiterates | Sector Perform → Sector Perform | |||
10/12/2023 | 11.55% | Truist Securities | $110 → $131 | Upgrade | Hold → Buy | |||
10/04/2023 | 21.76% | UBS | $139 → $143 | Maintains | Buy | |||
10/02/2023 | 14.1% | Morgan Stanley | $131 → $134 | Maintains | Overweight | |||
09/25/2023 | 18.36% | Mizuho | → $139 | Reiterates | Buy → Buy | |||
09/25/2023 | 11.55% | Morgan Stanley | $124 → $131 | Maintains | Overweight | |||
09/22/2023 | 10.69% | Wells Fargo | $127 → $130 | Maintains | Overweight | |||
09/22/2023 | 11.55% | Morgan Stanley | $124 → $131 | Maintains | Overweight |
FAQ
Exxon Mobil (XOM) 주식의 목표 가격은 얼마입니까?
Exxon Mobil (NYSE:XOM)의 최신 목표 주가는 11월 3, 2025에 Scotiabank에 의해 보고되었습니다. 이 애널리스트 기관은 $155.00에 대한 가격 목표를 설정했으며, 12개월 이내에 XOM이(가) rise될 것으로 예상합니다 (가능한 31.98% upside). 지난 1년간 39개의 애널리스트 기관이 평가를 보고했습니다.
Exxon Mobil (XOM)에 대한 가장 최근의 애널리스트 평가는 무엇인가요?
Exxon Mobil (NYSE:XOM)에 대한 최신 애널리스트 평가는 Scotiabank에 의해 제공되었으며, Exxon Mobil은(는) sector outperform 평가를 유지했다합니다.
Exxon Mobil (XOM)에 대한 마지막 업그레이드는 언제 있었나요?
Exxon Mobil Corp에 대한 마지막 업그레이드는 10월 10, 2024에 발생했습니다. 이 때 Scotiabank는 $145로 가격 목표를 올렸습니다. Scotiabank는 이전에 Exxon Mobil Corp에 대해 a sector perform를 가지고 있었습니다.
Exxon Mobil (XOM)에 대한 마지막 다운그레이드는 언제 있었나요?
Exxon Mobil Corp에 대한 마지막 다운그레이드는 10월 9, 2024에 발생했습니다. 이 때 Exane BNP Paribas가 Exxon Mobil Corp에 대해 가격 목표를 N/A에서 $105로 변경했습니다.
Exxon Mobil (XOM)에 대한 다음 애널리스트 평가는 언제 게시 또는 업데이트될 예정인가요?
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, Exxon Mobil의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. Exxon Mobil에 대한 마지막 평가는 11월 3, 2025에 제출되었으므로, 다음 평가가 11월 3, 2026쯤에 제공될 것으로 예상됩니다.
애널리스트 평가 Exxon Mobil (XOM)가 올바른가요?
평가는 주관적이며 변할 수 있지만, 최신 Exxon Mobil (XOM) 평가는 유지했다로, 가격 목표는 $128.00에서 $155.00으로 조정되었습니다. 현재 Exxon Mobil (XOM)의 가격은 $117.44로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한
사람들이 또한 지켜본다
© 2025 Benzinga | All Rights Reserved